Which? uses cookies to improve our sites and by continuing you agree to our cookies policy

Abandoned cosmetic filler victims to take action

Which? helps Isolagen patients who lost thousands


Woman preparing for cosmetic surgery

Always check the person carrying out your treatment has the right qualifications and experience

Which? is helping over 50 people to take action to win thousands of pounds in damages after they were abandoned by a cosmetic treatment company.

Isolagen offered patients who wanted to smooth their wrinkles a cosmetic filler which used their own skin cells.

Cells were taken during a biopsy and re-injected into the skin.

But in 2006, having left its customers with questionable results and out of pocket by about £3,500 each, the company withdrew from Britain.

Lax regulation

After being contacted by a Which? member who lost thousands of pounds to Isolagen with no results, Which? launched an online chat room to find others with similar stories.

It has now put the ‘Isolagen Action Group’ in contact with a legal firm specialising in cosmetic surgery negligence.

Which? health campaigner Jenny Driscoll, said: ‘This is a great example of ordinary people uniting to take on the business that has let them down.

‘Most people who have contacted us have complained of losing thousands of pounds and feeling deserted by the company that claimed it could help.

‘Isolagen was able to practice in Britain due to the lax regulation covering non-surgical treatments. The government should have done something; there should be rules in place to stop these products slipping through the net. Standing together will finally give these people a fair chance to win their money back.

‘We want to hear from more people who wish to join the Isolagen Action Group. Leave us your story on the cosmetic surgery section of our website and we’ll be in contact.’


Mike Saul, solicitor for TJ Legal based in Manchester who is representing the group, said: ‘It does seem that certain treatments can enter the market in the UK without adequate testing or analysis. The regulatory framework is not tight enough.

‘From the information I have, I am happy to act for the group in the pursuit of this matter. I am analysing all options, which may or may not include litigation.’

Back to top